A quick note; I briefly accessed copy of the aforesaid reports but have not thoroughly read them. Apparently, ages for the french study matched ages for the DiPALS study; a web based randomization program is mentioned but not identified . . . median survival of treatment group was 51 months, comparing to 28 months in the DiPALS study? Since the treatment groups appear to be older and extensive literature regards age as worse adverse factor in prognosis.